Victory Capital Management Inc. grew its position in shares of Globe Life Inc. (NYSE:GL - Free Report) by 2.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 445,639 shares of the company's stock after acquiring an additional 9,505 shares during the period. Victory Capital Management Inc. owned about 0.56% of Globe Life worth $63,713,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Intech Investment Management LLC increased its holdings in shares of Globe Life by 0.8% during the second quarter. Intech Investment Management LLC now owns 11,572 shares of the company's stock valued at $1,438,000 after acquiring an additional 95 shares in the last quarter. CX Institutional lifted its position in shares of Globe Life by 5.6% in the third quarter. CX Institutional now owns 1,805 shares of the company's stock valued at $258,000 after acquiring an additional 96 shares in the last quarter. KLP Kapitalforvaltning AS grew its holdings in Globe Life by 0.5% during the 3rd quarter. KLP Kapitalforvaltning AS now owns 22,000 shares of the company's stock valued at $3,145,000 after buying an additional 100 shares in the last quarter. Clearstead Advisors LLC increased its holdings in Globe Life by 1.9% in the 3rd quarter. Clearstead Advisors LLC now owns 5,273 shares of the company's stock valued at $754,000 after acquiring an additional 100 shares during the last quarter. Finally, Creative Planning boosted its stake in Globe Life by 0.3% during the second quarter. Creative Planning now owns 36,855 shares of the company's stock valued at $4,581,000 after buying an additional 101 shares during the last quarter. Hedge funds and other institutional investors own 81.61% of the company's stock.
Globe Life Trading Down 0.8%
NYSE GL opened at $143.57 on Friday. The firm's fifty day moving average price is $142.03 and its 200 day moving average price is $138.92. Globe Life Inc. has a 12 month low of $109.38 and a 12 month high of $152.71. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.07 and a quick ratio of 0.07. The company has a market capitalization of $11.29 billion, a price-to-earnings ratio of 10.20 and a beta of 0.46.
Globe Life (NYSE:GL - Get Free Report) last released its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.44 by ($0.05). The company had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.30%. The business's revenue was up 3.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, sell-side analysts expect that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.
Globe Life Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Friday, April 3rd will be issued a dividend of $0.33 per share. This is a boost from Globe Life's previous quarterly dividend of $0.27. This represents a $1.32 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, April 2nd. Globe Life's dividend payout ratio is currently 9.38%.
Insider Transactions at Globe Life
In related news, Director Mark A. Blinn sold 1,750 shares of the company's stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $147.91, for a total transaction of $258,842.50. Following the transaction, the director owned 3,372 shares of the company's stock, valued at approximately $498,752.52. This represents a 34.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CMO Jennifer Allison Haworth sold 10,000 shares of Globe Life stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $143.14, for a total value of $1,431,400.00. Following the completion of the sale, the chief marketing officer directly owned 17,479 shares of the company's stock, valued at approximately $2,501,944.06. This represents a 36.39% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 92,186 shares of company stock valued at $13,358,379 in the last three months. Insiders own 1.51% of the company's stock.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on the company. Weiss Ratings raised Globe Life from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Friday, February 13th. Piper Sandler reaffirmed an "overweight" rating and set a $167.00 price target on shares of Globe Life in a research report on Friday, November 21st. TD Cowen reissued a "buy" rating on shares of Globe Life in a report on Thursday, December 11th. Evercore set a $157.00 price objective on shares of Globe Life in a research note on Wednesday, February 18th. Finally, Truist Financial raised their price target on shares of Globe Life from $158.00 to $180.00 and gave the company a "buy" rating in a research note on Friday, February 6th. Eight research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $171.33.
Get Our Latest Stock Analysis on GL
About Globe Life
(
Free Report)
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report